Eli Competitors

LLY Stock   37.96  0.96  2.59%   
Eli Lilly competes with Merck, Merck CDR, and Amgen CDR; as well as few others. The company operates under Healthcare sector and is part of Drug Manufacturers - General industry. Analyzing Eli Lilly competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Eli Lilly to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Eli Lilly Correlation with its peers.

Eli Lilly vs Amgen CDR Correlation

Good diversification

The correlation between Eli Lilly and and AMGN is -0.19 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and AMGN in the same portfolio, assuming nothing else is changed.

Moving against Eli Stock

  0.4TCL-A TranscontinentalPairCorr
  0.38NSE New Stratus EnergyPairCorr
  0.37OBE Obsidian EnergyPairCorr
  0.36JNJ Johnson Johnson CDRPairCorr
  0.34DE Decisive Dividend CorpPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
35.5037.9740.44
Details
Intrinsic
Valuation
LowRealHigh
29.3931.8641.76
Details
Naive
Forecast
LowNextHigh
34.6437.1039.57
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
18.3137.4038.35
Details

Eli Lilly Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Eli Lilly and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Eli and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Eli Lilly does not affect the price movement of the other competitor.

Risk-Adjusted Indicators

There is a big difference between Eli Stock performing well and Eli Lilly Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eli Lilly's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Eli Lilly Competitive Analysis

The better you understand Eli Lilly competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Eli Lilly's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Eli Lilly's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
LLY MRK MRK AMGN
 2.59 
 37.96 
Eli
 3.23 
 27.83 
Merck
 3.23 
 27.83 
Merck
 0.94 
 29.02 
Amgen
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Total Asset
Short Ratio
Last Dividend Paid
Market Capitalization
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Revenue
Cash And Equivalents
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Eli Lilly Competition Performance Charts

Five steps to successful analysis of Eli Lilly Competition

Eli Lilly's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Eli Lilly in relation to its competition. Eli Lilly's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Eli Lilly in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Eli Lilly's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Eli Lilly, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Eli Lilly position

In addition to having Eli Lilly in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Recreation Thematic Idea Now

Recreation
Recreation Theme
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Eli Lilly Correlation with its peers.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Understanding that Eli Lilly's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Eli Lilly represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Eli Lilly's market price signifies the transaction level at which participants voluntarily complete trades.